BR0215752A - Pyanoindazoles and their use in the treatment of glaucoma - Google Patents
Pyanoindazoles and their use in the treatment of glaucomaInfo
- Publication number
- BR0215752A BR0215752A BR0215752-7A BR0215752A BR0215752A BR 0215752 A BR0215752 A BR 0215752A BR 0215752 A BR0215752 A BR 0215752A BR 0215752 A BR0215752 A BR 0215752A
- Authority
- BR
- Brazil
- Prior art keywords
- glaucoma
- treatment
- pyanoindazoles
- disclosed
- pyanoindoles
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
"PIRANOINDAZóIS E SEU USO NO TRATAMENTO DE GLAUCOMA". Divulgam-se piranoindazóis. Divulgam-se também métodos para a diminuição e controle de pressão intra-ocular normal ou elevada assim como um método para o tratamento de glaucoma usando composições contendo um ou mais dos compostos da invenção presente.s"Pyanoindoles and their use in the treatment of glaucoma". Pyranoindoles are disclosed. Methods for the reduction and control of normal or elevated intraocular pressure as well as a method for treating glaucoma using compositions containing one or more of the compounds of the present invention are also disclosed.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1686102A | 2002-05-30 | 2002-05-30 | |
PCT/US2002/039666 WO2003101379A2 (en) | 2002-05-30 | 2002-12-11 | Pyranoindazoles and their use for the treatment of glaucoma |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0215752A true BR0215752A (en) | 2005-03-29 |
Family
ID=29709135
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0215752-7A BR0215752A (en) | 2002-05-30 | 2002-12-11 | Pyanoindazoles and their use in the treatment of glaucoma |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1513521A2 (en) |
JP (1) | JP2005532337A (en) |
AU (1) | AU2002353122B2 (en) |
BR (1) | BR0215752A (en) |
CA (1) | CA2486832A1 (en) |
MX (1) | MXPA04011791A (en) |
WO (1) | WO2003101379A2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW200520760A (en) | 2003-12-15 | 2005-07-01 | Alcon Inc | Substituted [1,4] oxazino [2,3-g] indazoles for the treatment of glaucoma |
US7425572B2 (en) | 2004-12-08 | 2008-09-16 | Alcon, Inc. | Use of dioxindoindazoles and dioxoloindazoles for treating glaucoma |
TWI667233B (en) | 2013-12-19 | 2019-08-01 | 德商拜耳製藥公司 | Novel indazolecarboxamides, processes for their preparation, pharmaceutical preparations comprising them and their use for producing medicaments |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1392658A4 (en) * | 2001-06-01 | 2004-10-13 | Alcon Inc | Novel fused indazoles and indoles and their use for the treatment of glaucoma |
-
2002
- 2002-12-11 CA CA002486832A patent/CA2486832A1/en not_active Abandoned
- 2002-12-11 JP JP2004508737A patent/JP2005532337A/en active Pending
- 2002-12-11 WO PCT/US2002/039666 patent/WO2003101379A2/en active Application Filing
- 2002-12-11 AU AU2002353122A patent/AU2002353122B2/en not_active Ceased
- 2002-12-11 MX MXPA04011791A patent/MXPA04011791A/en unknown
- 2002-12-11 BR BR0215752-7A patent/BR0215752A/en not_active IP Right Cessation
- 2002-12-11 EP EP02790099A patent/EP1513521A2/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
JP2005532337A (en) | 2005-10-27 |
CA2486832A1 (en) | 2003-12-11 |
AU2002353122B2 (en) | 2008-01-31 |
AU2002353122A1 (en) | 2003-12-19 |
WO2003101379A2 (en) | 2003-12-11 |
EP1513521A2 (en) | 2005-03-16 |
WO2003101379A3 (en) | 2004-03-04 |
MXPA04011791A (en) | 2005-07-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0210241A (en) | Pyanoindazoles and their use in the treatment of glaucoma | |
BR0210238A (en) | New Aryl-Amino-Propane Analogs and Their Use for the Treatment of Glaucoma | |
BR0108175A (en) | Piperazine and piperidine derivatives for the treatment or prevention of neuronal damage. | |
WO2006071548A3 (en) | Aminopyrazine analogs for treating glaucoma and other rho kinase-mediated diseases | |
DE69521620T2 (en) | USE OF 9-DEOXYPROSTAGLAND IN DERIVATIVES FOR TREATING GLAUCOMA | |
ATE426413T1 (en) | METHODS AND COMPOSITIONS FOR TREATING OCCULAR NEOVASCULARIZATION AND NERVE INJURY | |
BR0109211A (en) | 5-ht1a Activity Compounds Useful for Treatment of External Retinal Disorders | |
BR0206639A (en) | Sterol Absorption Inhibitor (s) Combinations With Blood Modifier (s) For Treatment Of Vascular Conditions | |
SE9803710D0 (en) | Use of certain drugs for treating nerve root injury | |
DE69408309T2 (en) | AGENT FOR ARTIFICIAL TANNING AND PROTECTION OF THE SKIN AGAINST UV RAYS | |
WO2003075850A3 (en) | Methods for alzheimer's disease treatment and cognitive enhancement | |
TW200833341A (en) | 6-aminoimidazo[1,2-b]pyridazine analogs as rho kinase inhibitors for the treatment of rho kinase-mediated diseases and conditions | |
EP1440159A4 (en) | Bone morphogenic proteins (bmp), bmp receptors and bmp binding proteins and their use in the diagnosis and treatment of glaucoma | |
BR0317774A (en) | Use of rimexolone to treat dry eye | |
ES2192832T3 (en) | USE OF MACROLID COMPOUNDS TO TREAT GLAUCOMA. | |
DE60008143D1 (en) | LIPOXIN-A4 AND THEIR ANALOGS FOR THE TREATMENT OF DRY EYES | |
BR0209327A (en) | Composition for treatment of drug-induced constipation | |
DE69930271D1 (en) | MEDICAL COMPOSITIONS FOR THE TREATMENT OF EYE DISEASES | |
NO20052153L (en) | Piperazine and piperidine derivatives for the treatment of neurological diseases. | |
BR0314419A (en) | Substituted 5-chroman-5-yl-ethylamine compounds, their use and pharmaceutical composition including | |
BR9907715A (en) | Ophthalmic composition / method for treating corneal injury and / or impaired corneal esthesia, dry eye syndrome, hypolarcrimation and use of an aldose reductase inhibitor | |
BR0316775A (en) | New benzopyran analogues and their use for treating glaucoma | |
BR0215752A (en) | Pyanoindazoles and their use in the treatment of glaucoma | |
PT1131073E (en) | USE OF ESTAUROSPORIN DERIVATIVES FOR THE TREATMENT OF NEOVASCULAR EYE DISEASES | |
AU2001267864A1 (en) | Remedial agent for optic nerve disease and the like |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application fees: dismissal - article 86 of industrial property law |
Free format text: REFERENTE A(S) 8A ANUIDADE(S). |
|
B08K | Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87) |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2108 DE 31/05/2011. |